Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospektive, Randomisierte Doppelblinde Studie Zur Wirksamkeit Von Intestinal Retardiert Freigesetztem Phosphatidylcholine Bei therapierefraktärer Colitis Ulcerosa Mit Chronisch Aktivem Verlauf Unter Corticosteroiden

NCT00259545 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT00259545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00259545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospektive, Randomisierte Doppelblinde Studie Zur Wirksamkeit Von Intestinal Retardiert Freigesetztem Phosphatidylcholine Bei therapierefraktärer Colitis Ulcerosa Mit Chronisch Aktivem Verlauf Unter Corticosteroiden
Lead sponsor
Heidelberg University
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2003
Completion date
February 28, 2006
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

phosphatidylcholine, ulcerative colitis